Oncolytics Biotech Inc. (ONCY) Fundamentals

Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The company's product pipeline includes Bavencio, Keytruda, Retifanlimab, and Tecentriq.
SHARE INFORMATION
Market Cap$ 73,971,402
Shares Outstanding57,867,367
Float57,033,166
Percent Float98.69%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ 0.00
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions52
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months48,649
Institutional Holdings Percent1.6%
Institutional Sold Previous 3 Months371,784
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned17,414,380
TRADING INFO
52 Week High$ 2.38
52 Week Low$ 0.80
52 Week High Change$ -41.82
21 Day Moving Average$ 1.1013
21 Day Extended Moving Average$ 1.1394
50 Day Moving Average$ 1.055
50 Day Extended Moving Average$ 1.121
200 Day Moving Average$ 1.4781
200 Day Extended Moving Average$ 1.4734
10 Day Average Volume153,802
20 Day Average Volume107,997
30 Day Average Volume137,433
50 Day Average Volume128,824
Alpha0.018860
Beta2.2554
Standard Deviation0.497539
R20.051404
7 Day Price Change$ 0.109
7 Day Percent Change9.31%
21 Day Price Change$ 0.2818
21 Day Percent Change28.23%
30 Day Price Change$ 0.27
30 Day Percent Change26.73%
Month to Date Price Change$ 0.1328
Month to Date Percent Change11.58%
Quarter to Date Price Change$ 0.27
Quarter to Date Percent Change26.73%
180 Day Price Change$ -0.68
180 Day Percent Change-34.69%
200 Day Price Change$ -0.63
200 Day Percent Change-32.98%
Year to Date Price Change$ -0.11
Year to Date Percent Change-7.91%

Oncolytics Biotech Inc. (ONCY) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.70
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio18.00
Leverage Ratio1.30
Quick Ratio16.30
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio-3.40
Enterprise Value$ 42,875,371
Price to Sales0.00
Price to Free Cash-5.70
PE High Last 5 Years-5.20
Price To Book2.70
Price To Cash Flow0.00
PE Low Last 5 Years-3.20
Price to Tangible Book2.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-55.89
Return on Equity-69.23
Return on Capital-66.12

Oncolytics Biotech Inc. (ONCY) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKirk Look
CEOMatthew C. Coffey
Emplyoees26
Last AuditUQ
CIK0001129928
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address322 – 11th Avenue SW
Suite 804
Calgary, AB T2R-0C5
Websitehttps://www.oncolyticsbiotech.com
Facsimile+1 403 283-0858
Telephone+1 403 670-7377
Emailmmoore@oncolytics.ca


Your Recent History
NASDAQ
ONCY
Oncolytics..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.